252 related articles for article (PubMed ID: 32986074)
1. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
Tau N; Shepshelovich D
JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
[TBL] [Abstract][Full Text] [Related]
2. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
3. Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.
Reynolds IS; Rising JP; Coukell AJ; Paulson KH; Redberg RF
JAMA Intern Med; 2014 Nov; 174(11):1773-9. PubMed ID: 25265209
[TBL] [Abstract][Full Text] [Related]
4. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
5. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
6. Renewing the Call for Reforms to Medical Device Safety-The Case of Penumbra.
Kadakia KT; Beckman AL; Ross JS; Krumholz HM
JAMA Intern Med; 2022 Jan; 182(1):59-65. PubMed ID: 34842892
[TBL] [Abstract][Full Text] [Related]
7. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study.
Dhodapkar MM; Shi X; Ramachandran R; Chen EM; Wallach JD; Ross JS
BMJ; 2022 Oct; 379():e071752. PubMed ID: 36198428
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
9. Medical device vigilance at FDA.
Gross TP; Kessler LG
Stud Health Technol Inform; 1996; 28():17-24. PubMed ID: 10164091
[TBL] [Abstract][Full Text] [Related]
10. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.
Lalani C; Kunwar EM; Kinard M; Dhruva SS; Redberg RF
JAMA Intern Med; 2021 Sep; 181(9):1217-1223. PubMed ID: 34309624
[TBL] [Abstract][Full Text] [Related]
11. Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.
Downing NS; Shah ND; Aminawung JA; Pease AM; Zeitoun JD; Krumholz HM; Ross JS
JAMA; 2017 May; 317(18):1854-1863. PubMed ID: 28492899
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019.
Johnston JL; Dhruva SS; Ross JS; Rathi VK
JAMA Intern Med; 2020 Dec; 180(12):1701-1703. PubMed ID: 33044513
[TBL] [Abstract][Full Text] [Related]
13. New technology in electrophysiology: FDA process and perspective.
Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B
J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440
[TBL] [Abstract][Full Text] [Related]
14. Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration : A Cohort Study.
Tau N; Yahav D; Shepshelovich D
Ann Intern Med; 2020 Sep; 173(6):445-449. PubMed ID: 32716700
[TBL] [Abstract][Full Text] [Related]
15. Medical device regulation: an introduction for the practicing physician.
Maisel WH
Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
[TBL] [Abstract][Full Text] [Related]
16. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
17. Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database.
Beninger P; Murray M
Clin Ther; 2021 Feb; 43(2):380-395. PubMed ID: 33504449
[TBL] [Abstract][Full Text] [Related]
18. Descriptive analysis of postmarket surveillance data for hip implants.
Pane J; Verhamme KMC; Rebollo I; Sturkenboom MCJM
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):380-387. PubMed ID: 32128913
[TBL] [Abstract][Full Text] [Related]
19. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.
Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS
JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454
[TBL] [Abstract][Full Text] [Related]
20. FDA MAUDE data on complications with lasers, light sources, and energy-based devices.
Tremaine AM; Avram MM
Lasers Surg Med; 2015 Feb; 47(2):133-40. PubMed ID: 25655709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
